Baeres相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial

型糖尿病患者接受索玛鲁肽治疗后，根据慢性肾脏病严重程度评估其心血管结局：FLOW 试验

期刊:European Heart Journal

影响因子:35.6

doi:10.1093/eurheartj/ehae613

Mahaffey, Kenneth W; Tuttle, Katherine R; Arici, Mustafa; Baeres, Florian M M; Bakris, George; Charytan, David M; Cherney, David Z I; Chernin, Gil; Correa-Rotter, Ricardo; Gumprecht, Janusz; Idorn, Thomas; Pugliese, Giuseppe; Rasmussen, Ida Kirstine Bull; Rasmussen, Søren; Rossing, Peter; Sokareva, Ekaterina; Mann, Johannes F E; Perkovic, Vlado; Pratley, Richard

发表日期：2025

文献求助收藏

The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease

FLOW 是一项肾脏结局试验，旨在评估每周一次使用索玛鲁肽治疗 2 型糖尿病合并慢性肾脏病患者的疗效，本文将介绍该试验的理论依据、设计和基线数据。

期刊:Nephrology Dialysis Transplantation

影响因子:5.6

doi:10.1093/ndt/gfad009

Rossing, Peter; Baeres, Florian M M; Bakris, George; Bosch-Traberg, Heidrun; Gislum, Mette; Gough, Stephen C L; Idorn, Thomas; Lawson, Jack; Mahaffey, Kenneth W; Mann, Johannes F E; Mersebach, Henriette; Perkovic, Vlado; Tuttle, Katherine; Pratley, Richard

发表日期：2023

文献求助收藏

The prevalence of cardiovascular disease by vascular bed and impact on healthcare costs in a large, real-world population with type 2 diabetes

在一项大型真实世界2型糖尿病人群研究中，按血管床划分的心血管疾病患病率及其对医疗保健成本的影响

期刊:Endocrinology, Diabetes and Metabolism

影响因子:2.6

doi:10.1002/edm2.106

Weng, Wayne; Kong, Sheldon X; Ganguly, Rahul; Hersloev, Malene; Brett, Jason; Hobbs, Todd; Baeres, Florian M M

心血管疾病

发表日期：2020

文献求助收藏

LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial

LEADER 5：2 型糖尿病合并心血管高危患者的肥胖患病率及其对心血管代谢的影响：LEADER 试验的基线全球数据

期刊:Cardiovascular Diabetology

影响因子:10.6

doi:10.1186/s12933-016-0341-5

Masmiquel, L; Leiter, L A; Vidal, J; Bain, S; Petrie, J; Franek, E; Raz, I; Comlekci, A; Jacob, S; van Gaal, L; Baeres, F M M; Marso, S P; Eriksson, M

发表日期：2016

文献求助收藏

LEADER-4: blood pressure control in patients with type 2 diabetes and high cardiovascular risk: baseline data from the LEADER randomized trial

LEADER-4：2 型糖尿病合并高心血管风险患者的血压控制：LEADER 随机试验的基线数据

期刊:Journal of Hypertension

影响因子:4.1

doi:10.1097/HJH.0000000000000890

Petrie, John R; Marso, Steven P; Bain, Stephen C; Franek, Edward; Jacob, Stephan; Masmiquel, Luis; Leiter, Lawrence A; Haluzik, Martin; Satman, Ilhan; Omar, Mohamed; Shestakova, Marina; Van Gaal, Luc; Mann, Johannes F; Baeres, Florian M M; Zinman, Bernard; Poulter, Neil R

发表日期：2016

文献求助收藏

LEADER 7: cardiovascular risk profiles of US and European participants in the LEADER diabetes trial differ

LEADER 7：LEADER糖尿病试验中美国和欧洲参与者的心血管风险特征存在差异

期刊:Diabetology & Metabolic Syndrome

影响因子:3.9

doi:10.1186/s13098-016-0153-5

Rutten, Guy E H M; Tack, Cees J; Pieber, Thomas R; Comlekci, Abdurrahman; Ørsted, David Dynnes; Baeres, Florian M M; Marso, Steven P; Buse, John B

发表日期：2016

文献求助收藏

Initiation of once daily insulin detemir is not associated with weight gain in patients with type 2 diabetes mellitus: results from an observational study

一项观察性研究的结果显示，每日一次使用胰岛素地特米尔与2型糖尿病患者体重增加无关。

期刊:Diabetology & Metabolic Syndrome

影响因子:3.9

doi:10.1186/1758-5996-5-56

Yale, Jean-François; Damci, Taner; Kaiser, Marcel; Karnieli, Eddy; Khunti, Kamlesh; Liebl, Andreas; Baeres, Florian Mm; Svendsen, Anne Louise; Ross, Stuart A

免疫/内分泌

发表日期：2013

文献求助收藏

Observational study of once-daily insulin detemir in people with type 2 diabetes aged 75 years or older: a sub-analysis of data from the Study of Once daily LeVEmir (SOLVE)

一项针对 75 岁及以上 2 型糖尿病患者每日一次注射地特胰岛素的观察性研究：每日一次注射 LeVEmir 研究 (SOLVE) 数据的子分析

期刊:Drugs & Aging

影响因子:3.8

doi:10.1007/s40266-013-0054-3

Karnieli, Eddy; Baeres, Florian M M; Dzida, Grzegorz; Ji, Qiuhe; Ligthelm, Robert; Ross, Stuart; Svendsen, Anne Louise; Yale, Jean-François

免疫/内分泌

发表日期：2013

文献求助收藏